Nucleic Acid Therapeutics Congress: Asia

Nucleic Acid Therapeutics Congress: Asia is organized by Global Engage Ltd and will be held from Sep 09 - 10, 2025 at Holiday Inn Singapore Atrium, Singapore.

Description:
Global Engage is thrilled to host its inaugural Nucleic Acid Therapeutics Congress Asia 2025, uniting industry leaders and researchers to explore the latest research breakthroughs in this dynamic field. This congress will spotlight cutting-edge advancements in next-generation therapeutics, drug delivery innovations and the scientific journey from discovery to application. Emphasizing the importance of driving forward research and addressing how such advancements can eventually lead to scalable, market-ready solutions.

The 2-day congress, run on a single track, highlights these emerging trends and offers a platform for academic researchers, biotechnology and pharmaceutical industry professionals and healthcare providers to strategize to overcome barriers to research and development, including optimizing development pathways, securing funding and creating an ecosystem where long-term scientific progress can thrive. Through collaboration and knowledge-sharing, this congress aims to empower researchers and innovators in the region to make discoveries a reality.

Areas of Focus:

• Recent Scientific & Technological Advances: Explore the latest developments and emerging modalities in the field
• Engineering and Delivery Innovations: Advances in modification, modulation and delivery mechanisms
• Accelerating Translation & Adoption: Insights into clinical trials and approval pathways
• Supporting Development of Nucleic Acid Therapeutics in Asia: Strategies for commercialization, market entry and regional growth

This congress is tailored for pharmaceutical and biotechnology leaders, academic researchers, technology providers, startups and other key stakeholders to advance the science of nucleic acid therapeutics. It’s an opportunity you won’t want to miss!

Why Attend?

• Cutting-Edge Research: Access the latest developments in nucleic acid therapeutics, including RNA-based therapies, gene editing technologies, and emerging applications in personalized medicine
• Expert Insights: Learn from leading researchers and industry experts through keynote presentations, panel discussions, and workshops that delve into current challenges and future directions in the field
• Networking Opportunities: Connect with fellow scientists, researchers, and industry professionals, fostering collaborations that can enhance research initiatives and advance therapeutic developments
• Collaborative Environment: Engage in discussions with peers from diverse backgrounds, facilitating the exchange of ideas and best practices in nucleic acid research
• Regulatory Insights: Gain valuable insights into the regulatory landscape affecting nucleic acid therapies, helping you navigate compliance and market approval processes
• Impact on Healthcare: Be part of the conversation on how nucleic acid therapeutics are transforming approaches to treating diseases, allowing you to contribute to impactful research that can benefit patients worldwide